Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation (English, HTML)
Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation: English HTML file. From Health Canada, updated Sep 2023. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2023-09-01
The time to complete the screening of a drug submission with a rolling review is 25 days. Once the screening acceptance letter is issued, the review 1 period would begin. The submission would immediately be placed on “rolling review” until Health Canada receives all of the missing information, as indicated in the notice.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file